Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study - van Zandwijk, N; Pavlakis, N; Kao, S C (Lancet Oncol, 2017)
, et al.